Imaging in lung cancer: positron emission tomography scan

Vansteenkiste J.F.

Source: Eur Respir J 2002; 19: 49S-60S
Journal Issue: February 2002 - Suppl. 35
Disease area: Thoracic oncology

Congress or journal article abstractPDF journal article, handout or slidesFull text journal article

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Vansteenkiste J.F.. Imaging in lung cancer: positron emission tomography scan. Eur Respir J 2002; 19: 49S-60S

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Integrated PET/CT in the staging of nonsmall cell lung cancer: technical aspects and clinical integration
Source: Eur Respir J 2009; 33: 201-212
Year: 2009



The role of positron emission tomography with 18F-2-fluoro-2-deoxy-D-glucose in respiratory oncology
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-34-0, page=245
Year: 2004

Rebuttal
Source: Annual Congress 2005 - Lung cancer staging: not as simple as it seems?
Year: 2005

New imaging techniques in the treatment guidelines for lung cancer
Source: Eur Respir J 2002; 19: 71S-83S
Year: 2002



The place of non-invasive techniques (CT - PET - CT)
Source: Annual Congress 2007 - Mediastinal staging for NSCLC
Year: 2007


Imaging can replace mediastinoscopy: PRO
Source: Annual Congress 2005 - Lung cancer staging: not as simple as it seems?
Year: 2005

Imaging can replace mediastinoscopy: CON
Source: Annual Congress 2005 - Lung cancer staging: not as simple as it seems?
Year: 2005

The role of positron emission tomography with 18F-fluoro-2-deoxy-D-glucose in respiratory oncology
Source: Eur Respir J 2001; 17: 802-820
Year: 2001



Radiology of lung cancer
Source: Eur Respir Mon; 2009: 44: 106–135
Year: 2009

Preoperative evaluation of locally advanced non-small cell lung cancer after induction therapy by positron emission tomography with F-18-fluorodeoxyglucose (FDG-PET)
Source: Eur Respir J 2004; 24: Suppl. 48, 457s
Year: 2004

Accuracy of positron emission tomography with 18F-fluoro-deoxyglucose (FDG-PET) in diagnosis of recurrence of lung cancer after curative first-line therapy: visual and semiquantitative PET analysis
Source: Eur Respir J 2002; 20: Suppl. 38, 596s
Year: 2002

The use of SPECT in preoperative assessment of patients with lung cancer
Source: Eur Respir J 2004; 24: 258-262
Year: 2004



Positron emission tomography (PET) and computed tomography (CT) in the assessment of the mediastinum for patients with presumed or established lung cancer
Source: Annual Congress 2008 - Lung cancer and other malignant diseases involving the lungs
Year: 2008

The role of positron emission tomography scan in the preoperative staging of nonsmall cell lung cancer
Source: Annual Congress 2008 - Diagnostic and therapeutic problems in thoracic surgery
Year: 2008

Computed tomography in staging for lung cancer
Source: Eur Respir J 2002; 19: 40S-48S
Year: 2002



Evaluation of fluorine-18-fluorodeoxyglucose whole body positron emission tomography imaging in the clinical diagnosis of lung cancer
Source: Eur Respir J 2001; 18: Suppl. 33, 227s
Year: 2001

Integrated positron emission tomography-computed tomography (PET-CT) in the staging of lung cancer
Source: Annual Congress 2008 - New imaging modalities in the staging of lung cancer
Year: 2008


Detection of extrapulmonary lesions with integrated PET/CT in the staging of lung cancer
Source: Eur Respir J 2007; 29: 995-1002
Year: 2007



Radiotherapy planning based on positron emission tomography with fluordeoxyglucose in non small cell lung cancer – a pilot study
Source: Annual Congress 2008 - Therapy in thoracic oncology
Year: 2008


Diagnostic imaging of lung cancer
Source: Eur Respir J 2002; 19: 722-742
Year: 2002